|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20080300
Zabel et al. • Figure S1 Blood lymphocytes, BM neutrophils, and peritoneal macrophages do not detectably express mCCRL2.
• Figure S2 mCCRL2 is up-regulated on macrophages activated by specific cytokines and/or TLR ligands.
• Figure S3 mCCRL2 KO mice display a normal contact hypersensitivity response to FITC.
• Figure S4 mCCRL2 is dispensable for maximal tissue swelling in high dose IgE-mediated passive cutaneous anaphylaxis.
• Figure S5 Histological features of high dose IgE-dependent PCA reactions in WT BMCMC- vs. KO BMCMC-engrafted KitW-sh/Wsh mice.
• Figure S6 mCCRL2/L1.2 transfectants do not migrate to CCL2, CCL5, CCL7, or CCL8 in in vitro transwell chemotaxis.
• Figure S7 Lack of heterologous displacement of chemerin by other chemoattractants.
• Figure S8 Radioligand binding competition.
• Figure S9 Chemerin and/or CCL2 do not trigger intracellular calcium mobilization in CCRL2/HEK293 transfectants.
• Figure S10 CCRL2 amino-terminal sequence alignment.
• Figure S11 Freshly isolated peritoneal mast cells do not express CMKLR1.
• Figure S12 mRNA expression of mCCRL2.
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
